First Patient Randomised to EndoNET Breast Cancer Trial

First Patient Randomised to EndoNET Breast Cancer Trial

EndoNET is a multi-centre trial that evaluates whether endocrine treatment that prevents the production of oestrogens, when taken for 6 months prior to surgery, will shrink the tumour allowing for a reduction in the extent of surgery. 

for more information visit : EndoNET — Nuffield Department of Surgical Sciences (ox.ac.uk) 

or contact us on 01226 431067 barnsley.research@nhs.net 

News
Congratulations

Congratulations to the breast team

@barnshospital
@BarnsleyRD

for randomising their first participant! Thank you for all your support!

@NIHRCRN_yorks
@SITU_Oxford
@OCTRUctu
 
 
 
 
 
 
 
 
Source URL: https://www.barnsleyhospital.nhs.uk/research-and-development/news/first-patient-randomised-endonet-breast-cancer-trial

List of links present in page
  1. https://www.barnsleyhospital.nhs.uk/research-and-development/news/first-patient-randomised-endonet-breast-cancer-trial
  2. https://www.nds.ox.ac.uk/research/surgical-intervention-trials-unit/endonet
  3. mailto:barnsley.research@nhs.net
  4. https://www.barnsleyhospital.nhs.uk/taxonomy/term/11
  5. https://twitter.com/barnshospital
  6. https://twitter.com/BarnsleyRD
  7. https://twitter.com/NIHRCRN_yorks
  8. https://twitter.com/SITU_Oxford
  9. https://twitter.com/OCTRUctu